PCORI Participants Struggle To Avoid Discussing Cost In Hep C Rx Debate

By John Wilkerson / October 22, 2014 at 5:17 PM

Participants at PCORI's recent meeting on hepatitis C treatments struggled to avoid talking about cost because they said they wouldn't be holding a meeting on the treatments were they not so expensive.


Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.